HBM Partners has sold biotechnology company Brahms to listed trade buyer Thermo Fisher Scientific, in an all-cash deal that values the business at EUR 330m and generates a return of close to 22x money.
Company will now operate as Aurora Lichtwerke and was sold as part of a non-core asset divestment
Canadian GP previously owned around 20% of the listed education company
French bank BPCE mandated advisers to sell the Germany-based digital banking platform in 2018
ECI is currently investing from its ECI 11 fund, which closed on £700m on July 2018